Ngā hua rapu - Nicholas Cullen
- E whakaatu ana i te 1 - 20 hua o te 29
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
Peroneal tendon disorders mā Kinner Davda, Karan Malhotra, Paul O’Donnell, Dishan Singh, Nicholas Cullen
I whakaputaina 2017Revisão -
4
-
5
-
6
Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia mā Eske Christiane Gertje, Shorena Janelidze, Danielle van Westen, Nicholas Cullen, Erik Stomrud, Sebastian Palmqvist, Oskar Hansson, Niklas Mattsson
I whakaputaina 2023Artigo -
7
The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease mā Hlin Kvartsberg, Tammaryn Lashley, Christina E. Murray, Gunnar Brinkmalm, Nicholas Cullen, Kina Höglund, Henrik Zetterberg, Kaj Blennow, Erik Portelius
I whakaputaina 2018Artigo -
8
Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations mā Nicholas Cullen, Antoine Leuzy, Shorena Janelidze, Sebastian Palmqvist, Anna L. Svenningsson, Erik Stomrud, Jeffrey L. Dage, Niklas Mattsson, Oskar Hansson
I whakaputaina 2021Artigo -
9
NFL is a marker of treatment response in children with SMA treated with nusinersen mā Bob Olsson, Lars Alberg, Nicholas Cullen, Eva Michael, L. Wahlgren, Anna‐Karin Kroksmark, Kevin Rostásy, Kaj Blennow, Henrik Zetterberg, M. Tulinius
I whakaputaina 2019Artigo -
10
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures mā Sebastian Palmqvist, Pontus Tideman, Nicholas Cullen, Henrik Zetterberg, Kaj Blennow, Jeffrey L. Dage, Erik Stomrud, Shorena Janelidze, Niklas Mattsson, Oskar Hansson
I whakaputaina 2021Artigo -
11
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance mā Alexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, Jeffrey L. Dage, Randall J. Bateman, Henrik Zetterberg, Kaj Blennow, Erik Stomrud, Niklas Mattsson, Oskar Hansson
I whakaputaina 2022Artigo -
12
Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controll... mā Nicholas Cullen, Petr Novák, Duygu Tosun, Branislav Kováčech, Jozef Hanes, Eva Kontseková, Michal Fresser, Stefan Ropele, Howard Feldman, Reinhold Schmidt, Bengt Winblad, Norbert Žilka
I whakaputaina 2023Artigo -
13
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease mā Niklas Mattsson, Shorena Janelidze, Sebastian Palmqvist, Nicholas Cullen, Anna L. Svenningsson, Olof Strandberg, David Mengel, Dominic M. Walsh, Erik Stomrud, Jeffrey L. Dage, Oskar Hansson
I whakaputaina 2020Artigo -
14
Test‐retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models mā Nicholas Cullen, Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Tobias Bittner, Ivonne Suridjan, Alexander Jethwa, Gwendlyn Kollmorgen, Wagner S. Brum, Henrik Zetterberg, Kaj Blennow, Erik Stomrud, Oskar Hansson
I whakaputaina 2022Artigo -
15
Robustness of CSF Aβ42/40 and Aβ42/P‐tau181 measured using fully automated immunoassays to detect AD‐related outcomes mā Antoine Leuzy, Niklas Mattsson, Nicholas Cullen, Erik Stomrud, Sebastian Palmqvist, Renaud La Joie, Leonardo Iaccarino, Henrik Zetterberg, Gil D. Rabinovici, Kaj Blennow, Shorena Janelidze, Oskar Hansson
I whakaputaina 2023Artigo -
16
Convolutional Neural Networks with Template-Based Data Augmentation for Functional Lung Image Quantification mā Nicholas J. Tustison, Brian Avants, Zixuan Lin, Xue Feng, Nicholas Cullen, Jaime F. Mata, Lucía Flors, James C. Gee, Talissa A. Altes, John P. Mugler, Kun Qing
I whakaputaina 2018Artigo -
17
Tau‐PET is superior to phospho‐tau when predicting cognitive decline in symptomatic AD patients mā Ruben Smith, Nicholas Cullen, Alexa Pichet Binette, Antoine Leuzy, Kaj Blennow, Henrik Zetterberg, Gregory Klein, Edilio Borroni, Rik Ossenkoppele, Shorena Janelidze, Sebastian Palmqvist, Niklas Mattsson, Erik Stomrud, Oskar Hansson
I whakaputaina 2022Artigo -
18
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease mā Claudia Cicognola, Gunnar Brinkmalm, Jessica Wahlgren, Erik Portelius, Johan Gobom, Nicholas Cullen, Oskar Hansson, Lucilla Parnetti, Radu Constantinescu, Kristin R. Wildsmith, Hsu-Hsin Chen, Thomas G. Beach, Tammaryn Lashley, Henrik Zetterberg, Kaj Blennow, Kina Höglund
I whakaputaina 2018Artigo -
19
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A mul... mā Gemma Salvadó, Victoria Larsson, Karly Alex Cody, Nicholas Cullen, Erin M. Jonaitis, Erik Stomrud, Gwendlyn Kollmorgen, Norbert Wild, Sebastian Palmqvist, Shorena Janelidze, Niklas Mattsson, Henrik Zetterberg, Kaj Blennow, Sterling C. Johnson, Rik Ossenkoppele, Oskar Hansson
I whakaputaina 2023Artigo -
20
The ANTsX ecosystem for quantitative biological and medical imaging mā Nicholas J. Tustison, Philip A. Cook, Andrew J. Holbrook, Hans J. Johnson, John Muschelli, Gabriel A. Devenyi, Jeffrey Duda, Sandhitsu R. Das, Nicholas Cullen, Daniel L. Gillen, Michael A. Yassa, James R. Stone, James C. Gee, Brian Avants
I whakaputaina 2021Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Disease
Internal medicine
Alzheimer's disease
Dementia
Pathology
Oncology
Psychology
Biomarker
Cerebrospinal fluid
Cognitive decline
Psychiatry
Biochemistry
Biology
Cognition
Computer science
Neuroscience
Nuclear medicine
Neurodegeneration
Positron emission tomography
Cognitive impairment
Radiology
Alzheimer's Disease Neuroimaging Initiative
Ankle
Artificial intelligence
Chemistry
Database
Magnetic resonance imaging
Neuroimaging
Surgery